Pennsylvania recently published two new prescribing guidelines.
“These two prescribing guidelines developed by the Safe and Effective Prescribing Task Force are the latest available to assist healthcare providers as they treat their patients,” Dr. Rachel Levine, secretary of health, said. “These guidelines bring the total number to 14 available to physicians as they work to treat people who are already dealing with the disease of addiction. It is important that physicians look at a wide range of therapies as they work to treat these subsets of the population.”
The first guideline, Guidelines for the Safe Administration of Subanesthetic Ketamine, provides best practices for the subanesthetic administration of Ketamine, a nonopioid. Recommendations include information on patient selection, treatment location, the treatment team, and patient monitoring.
The second guideline, Treatment of Acute and Chronic Pain in Patients With Sickle Cell Disease (SCD), provides best practices for chronic pain and acute pain treatment. SCD patients often are outside the scope of other prescribing guidelines and also experience stigma and racial disparities.
The state’s Opioid Command Center was founded in 2018 as part of an opioid disaster declaration. Earlier this month, it published a strategic plan that outlines five goals: prevention, rescue, treatment, recovery and sustainability.